Exploratory investigation reveals parallel alteration of plasma fatty acids and eicosanoids in coronary artery disease patients

Vance, 2008 Van Meer, 2008, Membrance lipids: where they are and how they behave, Nat Rev Mol Cell Biol, 9, 112, 10.1038/nrm2330 Lundstrom, 2011, Lipid mediator profiling in pulmonary disease, Curr Pharm Biotechnol, 12, 1026, 10.2174/138920111795909087 Suhre, 2010, Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting, PLoS ONE, 11, e13953, 10.1371/journal.pone.0013953 Jones, 2003, Arachidonic acid and colorectal carcinogenesis, Mol Cell Biochem, 253, 141 Rakheja, 2005, Increased ratio of saturated to unsaturated C18 fatty acids in colonic adenocarcinoma: implications for cryotherapy and lipid raft function, Med Hypotheses, 65, 1120, 10.1016/j.mehy.2005.05.045 Ghadimi, 2008, Serum concentrations of fatty acids and colorectal adenoma risk: a case-control study in Japan, Asian Pac J Cancer P, 9, 111 Buczynski, 2010, Inflammatory hyperalgesia induces essential bioactive lipid production in the spinal cord, J Neurochem, 114, 981 Dawczynski, 2011, Incorporation of n-3 PUFA and γ-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis—a randomized controlled human intervention trial, Lipids Health Dis, 10, 130, 10.1186/1476-511X-10-130 Gleim, 2012, An eicosanoid-centric view of atherothrombotic risk factors, Cell Mol Life Sci, 69, 3361, 10.1007/s00018-012-0982-9 Siguel, 1994, Altered fatty-acid metabolism in patients with angiographically documented coronary-artery disease, Metabolism, 43, 982, 10.1016/0026-0495(94)90178-3 Erkkila, 2003, N-3 fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease, Am J Clin Nutr, 78, 65, 10.1093/ajcn/78.1.65 Fetterman, 2009, Therapeutic potential of n-3 polyunsaturated fatty acids in disease, Am J Health-Syst Pharm, 66, 1169, 10.2146/ajhp080411 Jönsson, 2003, Determination of cortisol in human saliva using liquid chromatography-electrospray tandem mass spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci, 784, 63, 10.1016/S1570-0232(02)00753-5 David, 2008, Chemotaxonomy of bacteria by comprehensive GC and GC–MS in electron impact and chemical ionisation mode, J Sep Sci, 31, 3395, 10.1002/jssc.200800215 Buyer, 2002, Identification of bacteria from single colonies by fatty acid analysis, J Microbiol Methods, 48, 259, 10.1016/S0167-7012(01)00327-X Tighe, 2000, Analysis of cellular fatty acids and phenotypic relationships of Agrobacterium, Bradyrhizobium, Mesorhizobium Rhizobium and Sinorhizobium species using the Sherlock Microbial Identification System, Int J Syst Evol Microbiol, 502, 787, 10.1099/00207713-50-2-787 Huys, 1995, Diversity of Aeromonas sp. in Flemish drinking water production plants as determined by gas–liquid chromatographic analysis of cellular fatty acid methyl esters (FAMEs), J Appl Bacteriol, 78, 445, 10.1111/j.1365-2672.1995.tb03432.x Liu, 2010, Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC–MS and multivariate statistical analysis, J Chromatogr B Analyt Technol Biomed Life Sci, 878, 2817, 10.1016/j.jchromb.2010.08.035 Tan, 2010, Identification of free fatty acids profiling of type 2 diabetes mellitus and exploring possible biomarkers by GC–MS coupled with chemometrics, Metabolomics, 6, 219, 10.1007/s11306-009-0189-8 Kumlin, 1996, Analytical methods for the measurement of leukotrienes and other eicosanoids in biological samples from asthmatic subjects, J Chromatogr A, 725, 29, 10.1016/0021-9673(95)01125-0 Rigas, 1993, Altered eicosanoid levels in human colon cancer, J Lab Clin Med, 122, 518 Tsikas, 2002, Application of gas chromatography–mass spectrometry and gas chromatography–tandem mass spectrometry to asses in vivo synthesis of prostaglandins, thromboxane, leukotrienes, isoprostanes and related compounds in humans, J Chromatogr B Analyt Technol Biomed Life Sci, 774, 205 Vandernoot, 2002, Capillary electrophoresis of cytochrome P-450 epoxygenase metabolites of arachidonic acid. 2. Resolution of stereoisomers, Anal Chem, 74, 5866, 10.1021/ac0259109 Yue, 2004, Determination of bioactive eicosanoids in brain tissue by sensitive reversed-phase liquid chromatographic method with fluorescence detection, J Chromatogr B Analyt Technol Biomed Life Sci, 803, 267, 10.1016/j.jchromb.2003.12.027 Bolcato, 2003, Determination of 20-hydroxyeicosatetraenoic acid in microsomal incubates using high-performance liquid chromatographic-mass spectrometry (HPLC–MS), J Chromatogr B Analyt Technol Biomed Life Sci, 794, 363, 10.1016/S1570-0232(03)00496-3 Mal, 2011, Ultra-pressure liquid chromatography/tandem mass spectrometry targeted profiling of arachidonic acid and eicosanoids in human colorectal cancer, Rapid Commun Mass Spectrom, 25, 755, 10.1002/rcm.4926 Dumlao, 2011, High-throughput lipidomic analysis of fatty acid eicosanoids and N-acylethanolamines, Biochim Biophys Acta, 1181, 724, 10.1016/j.bbalip.2011.06.005 Yang, 2009, Quantitative profiling method for oxylipin metabolome liquid chromatography electrospray ionization tandem mass spectrometry, Anal Chem, 81, 8085, 10.1021/ac901282n von Schacky, 2011, The Omega-3 Index as a risk factor for cardiovascular diseases, Prostaglandins Other Lipid Mediat, 96, 94, 10.1016/j.prostaglandins.2011.06.008 Mensink, 2003, Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials, Am J Clin Nutr, 77, 1146, 10.1093/ajcn/77.5.1146 Lichtenstein, 1998, Trans fatty acids: blood lipid levels, cholesterol metabolism and susceptibility to oxidation—a review, J Nutr Biochem, 9, 244, 10.1016/S0955-2863(98)00016-3 Simopoulos, 2008, The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases, Exp Biol Med, 233, 674, 10.3181/0711-MR-311 Hao, 2007, Physiologic and pathophysiologic roles of lipid mediators in the kidney, Kidney Int, 71, 1105, 10.1038/sj.ki.5002192 Shehbor, 2006, Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease, Free Radic Biol Med, 41, 1678, 10.1016/j.freeradbiomed.2006.09.001 Poeckel, 2010, The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease, Cardiovasc Res, 86, 243, 10.1093/cvr/cvq016 Manev, 2004, 5-Lipoxygenase as a putative link between cardiovascular and psychiatric disorders, Crit Rev Neurobiol, 16, 181, 10.1615/CritRevNeurobiol.v16.i12.190 Buchanan, M.R. United States Patent Application 20,040,115,749. Ruparel, 2012, The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolite-mediated peripheral inflammatory pain, Mol Pain, 8, 73, 10.1186/1744-8069-8-73 Alsalem, 2013, The contribution of the endogenous TRPV1 ligands 9-HODE and 13-HODE to nociceptive processing and their role in peripheral inflammatory pain mechanisms, Br J Pharmacol, 168, 1961, 10.1111/bph.12092 Spiteller, 1997, Spiteller G 9-hydroxy-10,12-octadecadienoic acid (9-HODE) and 13-hydroxy-9,11-octadecadienoic acid (13-HODE): excellent markers for lipid peroxidation, Chem Phys Lipids, 89, 131, 10.1016/S0009-3084(97)00070-4